Short course radiation for brain tumors in children
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a short course of radiation (fewer sessions) to help control symptoms from cancer that has spread to the brain or come back in the brain. It is for children and young adults whose cancer cannot be cured, and who are able to do some daily activities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or younger.
- You have an incurable cancer that has spread to the brain or started in the brain and came back.
- Your cancer team has agreed that radiation should be used to help with symptoms.
- You are able to do some daily activities (like playing or walking) at least 40% of the time.
- You are not planning to receive proton radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination treatment for children and young adults with brain tumors that have come back or not responded to standard therapy. The treatment includes a gene therapy (SGT-53) that delivers a normal TP53 gene, a checkpoint inhibitor drug that helps the immune system attack the cancer, and focused radiation. The goal is to see if this combination is safe and can shrink tumors.
This trial tests a new, shorter course of radiation therapy (called hypofractionation) for people with glioblastoma that has come back. It is for patients who have already had radiation and are doing well enough to consider another round.
This trial tests a new pattern of high-precision radiation (given over 3 days instead of 5) for people with a limited number of brain tumors from hard-to-treat cancers like melanoma or kidney cancer. The goal is to see if a shorter treatment schedule is just as effective and easier for patients.
This study tests a targeted radiation treatment for brain tumors that have spread from lung cancer and may not have responded to other treatments. The goal is to see if this precise radiation approach can shrink these tumors and improve survival with fewer side effects.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
This trial compares the usual short course of radiation therapy (one session) to a longer course (up to 5 sessions) for people with cancer that has spread to the brain. The goal is to see if the longer course works better and causes fewer side effects.
Hear when a new Central Nervous System Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.